STAR Compounds Show Potential to Treat GBA1-linked Parkinson’s

Preclinical studies with two compounds, GT-02287 and GT-02329, showed they could reduce the alpha-synuclein aggregates that characterize Parkinson’s and increase glucocerebrosidase protein levels in cell models of Parkinson’s and Gaucher disease.

16 November 2021 | Health

GT-02287 and GT-02329 are known as STARs, which stands for structurally targeted allosteric regulators. These regulators are designed to help mutated proteins fold correctly and recover their function.

The preclinical studies, conducted at the University of Maryland School of Medicine (UMSOM), evaluated GT-02287 and GT-02329 in Gaucher’s disease and in Parkinson’s that is associated with a mutated GBA1 gene. This gene encodes beta-glucocerebrosidase (GCase), an enzyme active in lysosomes (the recycling centers of the cell) that is known to be involved in these and other neurodegenerative diseases.

“This breakthrough in the ability to restore enzyme function for Parkinson’s Disease and Gaucher’s Disease is unprecedented for a small molecule and will contribute to a major shift in how we think about treating various neurodegenerative and lysosomal storage diseases with a genetic predisposition,” Eric I. Richman, Gain CEO, said in a press release.

“This brings tremendous hope to the population of individuals who are diagnosed with various forms of alpha synucleinopathies, including those with Parkinson’s Disease, Alzheimer’s, Lewy Body Dementia, and all forms of Gaucher’s Disease,” Richman added.

Researchers used induced pluripotent stem cells (iPSC) — cells that can be differentiated into numerous cell types — from patients with either GBA1-associated Parkinson’s or Gaucher to test the two candidates’ effectiveness. This “disease-in-a-dish” iPSC model allows for efficient testing of numerous candidates.

Results showed that both STARs, GT-02287 and GT-02329, can increase the levels of GCase and restore its activity in dopaminergic cells, the nerve cells that secrete dopamine and are affected in Parkinson’s. They also increased the localization of GCase to its place in the lysosome.

In general, data showed that GT-02287 and GT-02329 can bind to, stabilize, and restore the function of misfolded GCase proteins, leading to the restoration of GCase function and, subsequently, to the depletion of toxic aggregates of alpha-synuclein.

“Our studies in iPSC-derived cortical and dopaminergic neurons from neuronopathic Gaucher Disease patients show that these compounds significantly increase the levels of GCase protein, its transport to the lysosome, and its enzymatic activity,” said Ricardo Feldman, PhD, associate professor of microbiology and immunology at UMSOM.

“In dopaminergic neurons, the two lead STAR chaperones also decrease the levels of the hallmark of Parkinson’s Disease – [alpha-synuclein aggregates], demonstrating their potential to treat GBA1-associated Parkinson’s Disease,” said Ricardo Feldman, PhD, associate professor of microbiology and immunology at UMSOM.

The results obtained in cells were confirmed by data on a rat model of Parkinson’s disease, in which these STARS were found to reduce aggregation of alpha-synuclein proteins and reverse the neurodegenerative process, ultimately easing the animal’s locomotor activity.

“This data demonstrates that our STARs are able to guide misfolded forms of the GCase enzyme to their proper shape and restore enzymatic activity, establishing an important novel approach for direct treatment of GBA1 Parkinson’s Disease and other alpha-synucleinopathies,” said Manolo Bellotto, PhD, general manager at Gain Therapeutics.

These results were presented at The Michael J. Fox Foundation for Parkinson’s Research’s “Innovating from Drug Discover to the Clinic: Novel Approaches to PD Therapeutic Development” webinar.

The company believes that due to their small size, STARs might be administered as an oral medication and reach organs and tissues that may not be accessible through current therapeutic options.

It is also planning to start “IND [investigational new drug]-enabling studies for Gaucher and Parkinson’s Disease shortly,” Richman said. These studies support an IND application, a necessary step in getting U.S. Food and Drug Administration approval to open clinical trials of an investigational compound in people. Source: Parkinsonsnewstoday.com

Similar News

 

Churches condemn mandatory vaccination

16 hours ago | Health

ESTER KAMATIWINDHOEKThe Association of Christian Churches in Namibia (ACCN) has condemned the mandatory vaccination after some companies publicly implied that unvaccinated employees could lose their...

Cabinet to receive report on vaccination hesitancy

3 days ago - 21 January 2022 | Health

ELLANIE SMITWINDHOEKA report on Covid-19 vaccination hesitancy in Namibia will be presented to Cabinet.This report will focus on the findings of focus group discussions held...

Unvaccinated employees must test weekly, Namcor says

4 days ago - 20 January 2022 | Health

OGONE TLHAGE WINDHOEK The National Petroleum Corporation (Namcor) has effected its vaccination policy, having asked unvaccinated employees to present negative Covid-19 results...

23% of target population vaccinated

5 days ago - 19 January 2022 | Health

ELLANIE SMITWINDHOEKAs of the beginning of this week, Namibia has administered 413 876 first doses of Covid-19 vaccines, translating to 23.3% of the target population...

Child mortality expected to grow

6 days ago - 18 January 2022 | Health

ELLANIE SMIT WINDHOEK While recent statistics indicate that under-five child mortality has decreased in...

How meditation can help you make fewer mistakes

6 days ago - 18 January 2022 | Health

If you are forgetful or make mistakes when in a hurry, a new study from Michigan State University - the largest of its kind to...

Health ministry explains Trusted Travel System

6 days ago - 18 January 2022 | Health

ELLANIE SMITWINDHOEKAll travellers who are not fully vaccinated Namibians, Namibian permanent residents or truck drivers are still required to present negative Covid-19 PCR test results...

Two-year pandemic widens gap between rich and poor

1 week ago - 17 January 2022 | Health

JANA-MARI SMITH WINDHOEKNearly two years after the World Health Organisation (WHO) first sounded the...

Employees can consult labour ministry on mandatory vaccinations –...

1 week ago - 17 January 2022 | Health

NAMPA WINDHOEK Justice minister Yvonne Dausab has advised aggrieved employees subjected to mandatory Covid-19 vaccinations by their employers to consult the...

Covid: Deaths increased rapidly during fourth wave

1 week ago - 17 January 2022 | Health

ELLANIE SMIT WINDHOEKMore than 3 700 Namibians have already died from Covid-19, with the...

Latest News

U/20 trials an important starting...

16 hours ago | Sports

ANDREW POOLMANNewly appointed head coach Chrysander Botha accepted the challenge of putting together the strongest possible Namibian under-20 rugby team after the trials held in...

Desert Storm, Tugstsogt settle for...

16 hours ago | Sports

ATLANTIC CITY, N.J. — Sakaria (Desert Storm) Lukas stepped in to the opening bout of a Showtime Championship Boxing card, replacing the COVID-compromised Vic Pasillas in a...

Low volumes of cargo during...

16 hours ago | Economics

PHILLEPUS UUSIKUDuring the month of November 2021, exports amounting to N$5 billion, representing 56.6% of total exports left the country by sea, according to the...

NSFAF sticks to guns on...

16 hours ago | Justice

JEMIMA BEUKESThe Namibia Students Financial Assistance Fund (NSFAF) says the trust relationship between itself and its chief executive officer (CEO) Hilya Nghiwete has irretrievably broken...

Not our tradition – Onesi...

16 hours ago | Cultural

TUYEIMO HAIDULAONESIThe community of Onesi in the Omusati region is not in favour of legalising abortion because their tradition does not allow it.Speaking at the...

Churches condemn mandatory vaccination

16 hours ago | Health

ESTER KAMATIWINDHOEKThe Association of Christian Churches in Namibia (ACCN) has condemned the mandatory vaccination after some companies publicly implied that unvaccinated employees could lose their...

Corporates, don’t give up on...

16 hours ago | Sports

JESSE JACKSON KAURAISAWhen a child is misbehaving at home, as parents, our role is not to chase them away but to mentor them into becoming...

Five spots available for cyclists...

16 hours ago | Sports

NAMPA – The national coach at the cycling federation, Hans du Toit, says the Namibia Cycling Federation (NCF) will use upcoming races to select riders...

Poor nations to receive Merck...

16 hours ago | Economics

FRANCESCO GUARASCIONearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co's Covid-19 pill, under a landmark...

Load More